KANT: Kineta, Inc. Stock

by  •  • Comments Off on KANT: Kineta, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) -11.87
Book Value / Share -0.97
Price / Book n/a
NCAV ($M) -11.87
NCAV / Share -0.97
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -7.04
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.08
Current Ratio 0.08

Balance Sheet (mrq) ($M)
Current Assets 1.02
Assets 1.02
Liabilities 12.89
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -13.53
Net Income -17.13
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -11.57
Cash from Investing 0.00
Cash from Financing 6.35

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Armistice Capital, Llc 4.99 -38.92
2024-05-02 13D/A Bartoszek Raymond J. 16.20 103.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
ISCO – International Stem Cell Corporation IVBT – Innovation1 Biotech Inc.
IVEVF – Inventiva S.A. KAYS – Kaya Holdings, Inc.
KBYPF – Kobayashi Pharmaceutical Co., Ltd.


Financial data and stock pages provided by
Fintel.io